Stock ORGO ORGANOGENESIS HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Market Closed - Nasdaq
Other stock markets
 01:30:00 02/05/2024 am IST 		5-day change 1st Jan Change
2.51 USD +6.81% Intraday chart for Organogenesis Holdings Inc. -15.77% -38.63%
29/02 Transcript : Organogenesis Holdings Inc., Q4 2023 Earnings Call, Feb 29, 2024
29/02 Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Organogenesis Holdings Inc. Provides Earnings Guidance for the First Quarter and for the Year Ending December 31, 2024
Organogenesis Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Organogenesis Holdings Insider Sold Shares Worth $940,860, According to a Recent SEC Filing
Organogenesis Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Organogenesis Holdings Inc. Provides Earnings Guidance for the Year Ending December 31, 2023
Stocks wilt after early promise with US closed
Hopes of rate peak, China turnaround lift stocks
AIM WINNERS & LOSERS: Physiomics brings in COO; Ergomed receives bid
Advanced Medical issues profit warning following royalty issues
Advanced Medical Solutions Group Updates FY23 Guidance
Top Premarket Decliners
Organogenesis Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Organogenesis Holdings Inc. Withdraws Earnings Guidance for the the 2023
Organogenesis Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Organogenesis Holdings Inc. Provides Earnings Guidance for the Fiscal Year 2023
Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Organogenesis Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
Organogenesis Holdings Inc. Provides Earnings Guidance for the Fiscal Year 2023 Guidance
Organogenesis Holdings Inc. Reports Positive Interim Analysis of Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ORGO Stock
  4. News Organogenesis Holdings Inc.
  5. Other languages